Uterine leiomyosarcoma in patient receiving tamoxifen therapy

Acta Obstetricia et Gynecologica Scandinavica

Volumn 75, Issue 6, 1996, Pages 593-595

  McCluggage, Wilson Glenn ^a   Varma, Muralidharan ^a   Weir, Paul ^a   Bharucha, Hoshang ^b  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Estrogen receptors; Leiomyosarcoma; Progesterone receptors; Tamoxifen; Uterus

Indexed keywords

ANTIESTROGEN; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CASE REPORT; FEMALE; HUMAN; HYSTERECTOMY; HYSTEROSCOPY; LEIOMYOSARCOMA; MASTECTOMY; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; UTERUS BLEEDING;

EID: 0029946546     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016349609054678     Document Type: Article

References (21)

1. Wakeling AK, Bowler J. Biology and mode of action of pure antiestrogens. J. Steroid Biochem 1988: 30: 141-7.
2. Satyaswaroop PG, Zaino RJ, Mortel R. Estrogen-like effects of tamoxifen on human endometrial carcinoma transplanted into nude mice. Cancer Res 1984: 44; 4006-110.
3. Fornander T, Rutqvist LE, Cedermark B, Glas V, Mattson A, Siltversward C et al. Adjuvant tamoxifen in early breast cancer: occurrence of new primary tumours Lancet 1989: 1: 117-20.
4. Neven P, De Muylder X, Van Belle Y, Venderick G, De Muylder E. Tamoxifen and the uterus and endometrium. Lancet 1989: 1; 375.
5. Lahti E, Blanco G, Kauppila A, Apala-Sarkkinen M, Taskinen PJ, Laatikainen T. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 1993:81:660-4.
6. Malfetano J. Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients. Gynecol Oncol 1990: 39; 82-4.
7. Ismail SM. Pathology of endometrium treated with tamoxifen. J Clin Pathol 1994: 47; 827-33.
8. Silva KG, Tornos CS, Follen-Mitchell M. Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: the effects of tamoxifen. Int J Gynecol Pathol 1994: 13; 248-58.
9. Ferrazzi E, Cartei G, Mattarazo R, Fiorentino M. Oestrogen-like effect of tamoxifen on vaginal epithelium. Br Med J 1977: 1; 1351-2.
10. Boccardo F, Bruzzi P, Rubagotti A, Nocolo G, Rosso R, Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients. Oncology 1981:38; 281-5.
11. Buckley CH. Tamoxifen and endometriosis. Case Report. Br J Obstet Gynaecol 1990: 97; 645-6.
12. Najjar LR, Kim W, Nolan GH, Turner S, Raja UR. Intestinal and pelvic endometriosis presenting as a tumor and associated with tamoxifen therapy: Report of a case. Obstet Gynecol 1993: 82; 642-4.
13. Ugwumadu AHN, Bower D, Kin-Hoi Ho P. Tamoxifen induced adenomyosis and adenomyomatous endometrial polyp. Br J Obstet Gynaecol 1993: 100; 386-92.
14. Blocklage T, Lee KR, Belinsin JL. Uterine Mullerian adenosarcoma following adenomyoma in a woman on tamoxifen therapy. Gynecol Oncol 1992: 44; 104-9.
15. Altaras MM, Aviram R, Cohen I, Cordoba M, Yarkoni S, Beyth Y. Role of prolonged stimulation of tamoxifen therapy in the etiology of endometrial sarcomas. Gynecol Oncol 1993: 49; 255-8.
16. Clarke MR. Uterine malignant mixed Mullerian tumor in a patient on longterm tamoxifen therapy for breast cancer. Gynecol Oncol 1993: 51; 411-5.
17. Seoud MA-F, Johnson J, Weed JC. Gynecologic tumors in tamoxifen-treated women with breast cancer. Obstet Gynecol 1993: 82; 165-9.
18. Dilts PV, Hopkins MP, Chang AK, Cody RL. Rapid growth of leiomyoma in patient receiving tamoxifen. Am J Obstet Gynecol 1992: 166; 167-8.
19. Leo L, Lanza A, Tessarolo RM, Bellino R, Lauricella A, Wierdis T. Leiomyomas in patients receiving tamoxifen. Clin Exp Obstet Gynecol 1994: 21: 94-8.
20. Ugwumadu AHN, Harding K. Uterine leiomyomata and endometrial proliferation in postmenopausal women treated with the anti-oestrogen tamoxifen. Eur J Obstet Gynecol Reprod Biol 1994: 54; 153-6.
21. Press MF, Nousek-Goebl NA, Bur M, Greene GL. Estrogen receptor localization in the female genital tract. Am J Pathol 1986: 123; 280-92.